These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 28057871

  • 1. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [Abstract] [Full Text] [Related]

  • 2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 01; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb 01; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

  • 4. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY, Yu CH, Kim JS, Kang YJ, Kwon O, Choi JY, Cho JH, Kim CD, Kim YL, Park SH.
    Korean J Intern Med; 2015 May 01; 30(3):345-53. PubMed ID: 25995665
    [Abstract] [Full Text] [Related]

  • 5. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).
    Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJ, Groenier KH, Struck J, de Jong PE, Bilo HJ, Kleefstra N, Gansevoort RT.
    Diabetologia; 2013 Aug 01; 56(8):1680-8. PubMed ID: 23624546
    [Abstract] [Full Text] [Related]

  • 6. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A, Lu Y, Kawano H, Horie S, Muto S.
    Clin Exp Nephrol; 2015 Dec 01; 19(6):1199-205. PubMed ID: 25715868
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of NGAL staining in patients with IgA nephropathy.
    Yavas H, Sahin OZ, Ersoy R, Taşlı F, Gibyeli Genek D, Uzum A, Cirit M.
    Ren Fail; 2013 Dec 01; 35(4):472-6. PubMed ID: 23413884
    [Abstract] [Full Text] [Related]

  • 8. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
    Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP.
    Am J Kidney Dis; 2013 Mar 01; 61(3):420-9. PubMed ID: 23089511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B, Yu DR, Lv JC, Lin Y, Li Q, Yin JZ, Du YY, Tang XL, Mao LC, Li QF, Sun Y, Liu L, Li XF, Fei D, Wei XY, Zhu CF, Cheng XX, Chen HY, Wang YJ.
    Am J Nephrol; 2018 Mar 01; 48(2):127-136. PubMed ID: 30110674
    [Abstract] [Full Text] [Related]

  • 11. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan 01; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

  • 12. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
    Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, Fumeron F, Potier L, Marre M, Hadjadj S, Roussel R.
    Cardiovasc Diabetol; 2018 Aug 02; 17(1):110. PubMed ID: 30071874
    [Abstract] [Full Text] [Related]

  • 13. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 02; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E, Machowska A, Stenvinkel P, Lindholm B.
    Curr Protein Pept Sci; 2017 May 02; 18(12):1232-1243. PubMed ID: 28714397
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D, Liu J, Duan S, Chen P, Tang L, Zhang L, Feng Z, Cai G, Wu J, Chen X.
    Kidney Blood Press Res; 2018 May 02; 43(2):318-328. PubMed ID: 29529608
    [Abstract] [Full Text] [Related]

  • 16. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 02; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 17. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y.
    PLoS One; 2015 Mar 02; 10(4):e0122212. PubMed ID: 25860248
    [Abstract] [Full Text] [Related]

  • 18. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.
    Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A, Vogt B, Burnier M, Martin PY, Devuyst O, Bochud M.
    J Am Soc Nephrol; 2015 Jun 02; 26(6):1415-25. PubMed ID: 25270071
    [Abstract] [Full Text] [Related]

  • 19. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    Zittema D, Casteleijn NF, Bakker SJ, Boesten LS, Duit AA, Franssen CF, Gaillard CA, Gansevoort RT.
    PLoS One; 2017 Jun 02; 12(1):e0169263. PubMed ID: 28081165
    [Abstract] [Full Text] [Related]

  • 20. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
    Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili-Munoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R.
    Diabetes Care; 2013 Nov 02; 36(11):3639-45. PubMed ID: 23863910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.